Literature DB >> 16943295

Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity.

John W Schoggins1, Erik Falck-Pedersen.   

Abstract

Fiber and penton base capsid proteins of adenovirus type 5 (Ad5) mediate a well-characterized two-step entry pathway in permissive tissue culture cell lines. Fiber binds with high affinity to the cell surface coxsackievirus-and-adenovirus receptor (CAR), and penton base facilitates viral internalization by binding alphav integrins through an RGD motif. In vivo, the entry pathway is complicated by interactions of capsid proteins with additional cell surface molecules and blood factors. When administered systemically in mice, adenovirus vectors (Adv) localize primarily to hepatic tissue, resulting in efficient gene transduction and potent activation of the host antiviral immune response. The goal of the present study was to detarget Adv uptake through fiber and penton base capsid protein manipulations and determine how detargeted vectors influence transduction efficiency, inflammatory activation, and activation of the adaptive arm of the immune system. By manipulating fiber and the penton base, we have generated highly detargeted vectors (up to 1,200-fold reduction in transgene expression in vivo) with reduced macrophage stimulatory activity in vitro and in vivo. In spite of the diminished transduction and macrophage activation, the detargeted vectors induce strong neutralizing immunity as well as efficient antitransgene antibody. Three of the modified vectors produce antitransgene humoral immunity at levels that exceed or are equal to that seen with an unmodified Ad5-based vector. The fiber-pseudotyped and penton base constructs with RGD deleted have attributes that could be important enhancements in a number of vaccine applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943295      PMCID: PMC1641751          DOI: 10.1128/JVI.01359-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.

Authors:  Naoya Koizumi; Hiroyuki Mizuguchi; Fuminori Sakurai; Teruhide Yamaguchi; Yoshiteru Watanabe; Takao Hayakawa
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  A hemodynamic response to intravenous adenovirus vector particles is caused by systemic Kupffer cell-mediated activation of endothelial cells.

Authors:  Gudrun Schiedner; Wilhelm Bloch; Sabine Hertel; Marion Johnston; Andrei Molojavyi; Volker Dries; Georg Varga; Nico Van Rooijen; Stefan Kochanek
Journal:  Hum Gene Ther       Date:  2003-11-20       Impact factor: 5.695

3.  Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells.

Authors:  Theresa Vincent; Ralf F Pettersson; Ronald G Crystal; Philip L Leopold
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 4.  Immune responses to gene therapy vectors: influence on vector function and effector mechanisms.

Authors:  N Bessis; F J GarciaCozar; M-C Boissier
Journal:  Gene Ther       Date:  2004-10       Impact factor: 5.250

5.  Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons.

Authors:  Shaoheng Ni; Kathrin Bernt; Anuj Gaggar; Zong-Yi Li; Hans-Peter Kiem; André Lieber
Journal:  Hum Gene Ther       Date:  2005-06       Impact factor: 5.695

6.  Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment.

Authors:  T J Wickham; P Mathias; D A Cheresh; G R Nemerow
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

7.  Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway.

Authors:  Nicola J Philpott; Marcelo Nociari; Keith B Elkon; Erik Falck-Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

8.  Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates.

Authors:  Theodore A G Smith; Neeraja Idamakanti; Jennifer Marshall-Neff; Michele L Rollence; Patrick Wright; Michele Kaloss; Laura King; Christine Mech; Lisa Dinges; William O Iverson; Alfred D Sherer; Judit E Markovits; Russette M Lyons; Michael Kaleko; Susan C Stevenson
Journal:  Hum Gene Ther       Date:  2003-11-20       Impact factor: 5.695

9.  Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses.

Authors:  Stefan Worgall; Annette Busch; Michael Rivara; David Bonnyay; Philip L Leopold; Robert Merritt; Neil R Hackett; Peter W Rovelink; Joseph T Bruder; Thomas J Wickham; Imi Kovesdi; Ronald G Crystal
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice.

Authors:  Theodore A G Smith; Neeraja Idamakanti; Michele L Rollence; Jennifer Marshall-Neff; Jin Kim; Kathy Mulgrew; Glen R Nemerow; Michael Kaleko; Susan C Stevenson
Journal:  Hum Gene Ther       Date:  2003-05-20       Impact factor: 5.695

View more
  18 in total

Review 1.  Novel recombinant alphaviral and adenoviral vectors for cancer immunotherapy.

Authors:  Takuya Osada; Michael A Morse; Amy Hobeika; H Kim Lyerly
Journal:  Semin Oncol       Date:  2012-06       Impact factor: 4.929

2.  Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator.

Authors:  Marcelo Nociari; Oksana Ocheretina; John W Schoggins; Erik Falck-Pedersen
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

3.  Sensing adenovirus infection: activation of interferon regulatory factor 3 in RAW 264.7 cells.

Authors:  Saskia C Stein; Erik Falck-Pedersen
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

4.  E3 ubiquitin ligase Mindbomb 1 facilitates nuclear delivery of adenovirus genomes.

Authors:  Stephanie L Sarbanes; Vincent A Blomen; Eric Lam; Søren Heissel; Joseph M Luna; Thijn R Brummelkamp; Erik Falck-Pedersen; H-Heinrich Hoffmann; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 11.205

5.  Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber.

Authors:  John W Schoggins; Erik Falck-Pedersen
Journal:  Virology       Date:  2009-09-25       Impact factor: 3.616

6.  Adenovirus induction of IRF3 occurs through a binary trigger targeting Jun N-terminal kinase and TBK1 kinase cascades and type I interferon autocrine signaling.

Authors:  Marcelo Nociari; Oksana Ocheretina; Mary Murphy; Erik Falck-Pedersen
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

Review 7.  The influence of innate and pre-existing immunity on adenovirus therapy.

Authors:  Anne K Zaiss; Hidevaldo B Machado; Harvey R Herschman
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429

8.  Adenovirus detection by the cGAS/STING/TBK1 DNA sensing cascade.

Authors:  Eric Lam; Saskia Stein; Erik Falck-Pedersen
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

9.  Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo.

Authors:  Nelson C Di Paolo; Edward A Miao; Yoichiro Iwakura; Kaja Murali-Krishna; Alan Aderem; Richard A Flavell; Thalia Papayannopoulou; Dmitry M Shayakhmetov
Journal:  Immunity       Date:  2009-07-02       Impact factor: 31.745

10.  Evaluation of biodistribution and safety of adenovirus vector containing MDR1 in mice.

Authors:  ZhenZhen Zhao; Wei Liu; Yuxi Su; Jin Zhu; GaiHuan Zheng; Qing Luo; XianQing Jin
Journal:  J Exp Clin Cancer Res       Date:  2010-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.